Alejandro Pérez-Cabeza

6PUBLICATIONS
25CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Cardiology (incl. cardiovascular diseases)Medical devicesEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 14, 2026
Intra-Individual Variability of Lipoprotein(a) After Acute Coronary Syndrome: A Long-Term Cohort Study.

Nelsa González-Aguado, Jose Ignacio Larrubia-Valle, Rafael Franco-Hita

|Mar 14, 2026
Impact of Lipoprotein(a) on Residual Cardiovascular Risk After an Acute Coronary Syndrome.

Nelsa González-Aguado, Rafael Franco-Hita, Jose Ignacio Larrubia-Valle

|Aug 14, 2025
Practical Comprehensive Approach to Current Atrial Fibrillation Challenges: Insights from an Expert Panel.

Carlos Escobar, Miguel Camafort, Elena Fortuny

|Feb 07, 2023
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban.

Francisco Marín, Marcelo Sanmartín Fernández, Gonzalo Barón-Esquivias

|Sep 23, 2022
Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries.

Francisco Marin, Marcelo Sanmartín Fernández, Iñaki Lekuona

|Aug 01, 2018
TIMI-AF score and cardiovascular events in vitamin K antagonists-naïve outpatients with atrial fibrillation.

Alejandro Isidoro Pérez Cabeza, Rafael Bravo Marques, Pedro Antonio Chinchurreta Capote

Pageof 1